Clear Cell Renal Cell Carcinoma
Conditions
Interventions
This study was observational and did not involve group assignment.:The samples of renal clear cell carcinoma will be collected for metabolomics sequencing, enzyme-linked immunosorbent assay, Western b
Sponsors
The First Affiliated Hospital of Naval Medical University of PLA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with a clinical diagnosis of kidney cancer who met the following criteria: (1) Patients of both sexes, aged 18-80 years old, signed informed consent voluntarily; (2) Patients who received partial nephrectomy or radical nephrectomy as the first line treatment and were diagnosed as renal clear cell carcinoma by pathological examination of surgical specimens; (3) The amount of tumor tissue and adjacent normal kidney tissue were more than 300mg without affecting the pathological examination.
Exclusion criteria
Exclusion criteria: (1) Patients with neoadjuvant therapy before surgery; (2) Patients with metabolic diseases, such as diabetes, hypertension, hyperlipidemia, coronary atherosclerotic heart disease, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enrichment of metabolites; | — |
Secondary
| Measure | Time frame |
|---|---|
| Expression of metabolites related proteins; | — |
Countries
China
Contacts
Public ContactLinhui Wang
The First Affiliated Hospital of Naval Medical University of PLA
Outcome results
None listed